WallStreetZenWallStreetZen

NASDAQ: TIL
Instil Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TIL

Based on 2 analysts offering 12 month price targets for Instil Bio Inc

Min Forecast
$125.00+732.22%
Avg Forecast
$125.00+732.22%
Max Forecast
$125.00+732.22%

Should I buy or sell TIL stock?

Based on 2 analysts offering ratings for Instil Bio Inc.

Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TIL's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates TIL as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their TIL stock forecasts and price targets.

TIL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-11
lockedlocked$00.00+00.00%2025-06-05

1 of 1

Forecast return on equity

Is TIL forecast to generate an efficient return?

Company
N/A
Industry
247.01%
Market
230.21%

Forecast return on assets

Is TIL forecast to generate an efficient return on assets?

Company
N/A
Industry
98.7%

TIL earnings per share forecast

What is TIL's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$12.34
Avg 2 year Forecast
-$10.50
Avg 3 year Forecast
-$8.36

TIL revenue forecast

What is TIL's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

TIL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TIL$15.02$125.00+732.22%Buy
ESLA$2.76$16.00+479.71%Strong Buy
ANEB$2.50$3.00+20.00%Strong Buy
WHWK$2.10N/AN/A
OKYO$2.63$7.00+166.16%Buy
View Top Biotech Stocks

Instil Bio Stock Forecast FAQ

Is Instil Bio Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: TIL) stock is to Buy TIL stock.

Out of 2 analysts, 0 (0%) are recommending TIL as a Strong Buy, 2 (100%) are recommending TIL as a Buy, 0 (0%) are recommending TIL as a Hold, 0 (0%) are recommending TIL as a Sell, and 0 (0%) are recommending TIL as a Strong Sell.

If you're new to stock investing, here's how to buy Instil Bio stock.

What is TIL's earnings growth forecast for 2025-2027?

(NASDAQ: TIL) Instil Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 48.78%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 43.04%.

Instil Bio's earnings in 2025 is -$84,510,000.On average, 5 Wall Street analysts forecast TIL's earnings for 2025 to be -$83,284,933, with the lowest TIL earnings forecast at -$87,658,047, and the highest TIL earnings forecast at -$81,869,308. On average, 5 Wall Street analysts forecast TIL's earnings for 2026 to be -$70,897,370, with the lowest TIL earnings forecast at -$100,360,194, and the highest TIL earnings forecast at -$52,878,358.

In 2027, TIL is forecast to generate -$56,454,888 in earnings, with the lowest earnings forecast at -$54,778,010 and the highest earnings forecast at -$58,690,725.

What is TIL's revenue growth forecast for 2025-2027?

(NASDAQ: TIL) Instil Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 109.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.12%.

Instil Bio's revenue in 2025 is $0.On average, 5 Wall Street analysts forecast TIL's revenue for 2025 to be $0, with the lowest TIL revenue forecast at $0, and the highest TIL revenue forecast at $0. On average, 5 Wall Street analysts forecast TIL's revenue for 2026 to be $0, with the lowest TIL revenue forecast at $0, and the highest TIL revenue forecast at $0.

In 2027, TIL is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is TIL's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: TIL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 98.7%.

What is TIL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TIL price target, the average TIL price target is $125.00, with the highest TIL stock price forecast at $125.00 and the lowest TIL stock price forecast at $125.00.

On average, Wall Street analysts predict that Instil Bio's share price could reach $125.00 by Sep 11, 2026. The average Instil Bio stock price prediction forecasts a potential upside of 732.22% from the current TIL share price of $15.02.

What is TIL's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: TIL) Instil Bio's current Earnings Per Share (EPS) is -$12.92. On average, analysts forecast that TIL's EPS will be -$12.34 for 2025, with the lowest EPS forecast at -$12.99, and the highest EPS forecast at -$12.13. On average, analysts forecast that TIL's EPS will be -$10.50 for 2026, with the lowest EPS forecast at -$14.87, and the highest EPS forecast at -$7.83. In 2027, TIL's EPS is forecast to hit -$8.36 (min: -$8.11, max: -$8.69).

What is TIL's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: TIL) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.